<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04055727</url>
  </required_header>
  <id_info>
    <org_study_id>SepsisSoS</org_study_id>
    <nct_id>NCT04055727</nct_id>
  </id_info>
  <brief_title>Sepsis at Södersjukhuset-Adherence to Treatment Guidelines</brief_title>
  <official_title>Sepsis at Södersjukhuset-Adherence to Treatment Guidelines</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Karolinska Institutet</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Karolinska Institutet</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A retrospective single-center study with patients with suspected sepsis admitted to the
      Emergency Department at Södersjukhuset during a period of two years. The aim is to describe
      the association between adherence to treatment guidelines, gender, incidence and mortality
      for patients with sepsis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this single-center study, patients with suspected sepsis admitted to the Emergency
      Department at Södersjukhuset during a period of two years will be included. About 11,000
      patients will be included. Patient data including described sepsis symptoms will be drawn
      from the electronic medical record, TakeCare and Clinisoft. Logistic regression analysis will
      adjust for age, gender, comorbidity according to Charlson score, vital signs, with
      preliminary focus of infection (pneumonia, urinary tract infection, abdominal, other,
      unknown). The Surviving Sepsis guidelines for the time period are: 3-hour bundle including
      lactate measurement, obtaining blood culture, fluid treatment if hypotensive and
      administration of broad-spectrum antibiotics. The 6-hour bundles with administration of
      vasopressors if needed, remeasure lactate if elevated, with persistent hypotension re-asses
      volume status and tissue perfusion. Time zero is defined as the admission time to the
      emergency department. The aim is to describe the association between adherence to treatment
      guidelines, gender, incidence and mortality for patients with sepsis.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 7, 2019</start_date>
  <completion_date type="Anticipated">December 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Gender differences in 90-day mortality</measure>
    <time_frame>90 days</time_frame>
    <description>Gender differences in percentage of patients who died before day 90</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Association between adherence to treatment guidelines and mortality</measure>
    <time_frame>90 days</time_frame>
    <description>Association between number of completed sepsis bundles and mortality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of sepsis</measure>
    <time_frame>90 days</time_frame>
    <description>Number of patients admitted to the Emergency Department at Södersjukhuset during the study period comparing to the hospitals catchment area</description>
  </secondary_outcome>
  <enrollment type="Anticipated">11000</enrollment>
  <condition>Sepsis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients admitted to the emergency department at Södersjukhuset
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:

        • Patients admitted to the Emergency Department at Södersjukhuset with suspicion of sepsis
        defined as blood cultures taken and intravenous antibiotics of type beta-lactam or
        aminoglycoside prescribed within 48 hours of admission.

        Exclusion criteria:

        • Patients transferred from other hospitals or treatment clinics.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Katarina Bohm, Ass Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Karolinska Institutet</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sandra Jonmarker</last_name>
    <phone>+4686162238</phone>
    <phone_ext>+46709676710</phone_ext>
    <email>sandra.jonmarker@sll.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Katarina Bohm, Ass Prof</last_name>
    <phone>+46736403013</phone>
    <email>katarina.bohm@ki.se</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Södersjukhuset</name>
      <address>
        <city>Stockholm</city>
        <zip>11880</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sandra Jonmarker</last_name>
      <phone>+46709676710</phone>
      <email>sandra.jonmarker@sll.se</email>
    </contact>
    <contact_backup>
      <last_name>Katarina Bohm, Ass prof</last_name>
      <phone>+46736403013</phone>
      <email>katarina.bohm@ki.se</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>August 12, 2019</study_first_submitted>
  <study_first_submitted_qc>August 13, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 14, 2019</study_first_posted>
  <last_update_submitted>August 13, 2019</last_update_submitted>
  <last_update_submitted_qc>August 13, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 14, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Karolinska Institutet</investigator_affiliation>
    <investigator_full_name>Katarina Bohm</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>treatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Toxemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

